Dodávky léčivých přípravků s účinnou Vedolizumab
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
30 / 100
Risk factors
Selection criteria not detailed in the notice; bidders may face unexpected requirements from procurement documents.
Price-only award could lead to aggressive pricing and low margins.
Submission deadline in 7 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- CZK 30.6M estimated value
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Jul 2030
- Supply of medicinal product with active substance Vedolizumab
- Delivery on an as-needed basis according to buyer's actual requirements
Show full summary
Open tender for supply of medicinal products with active substance Vedolizumab for Moravskoslezská nemocnice Frýdek-Místek. Framework agreement with a single lot, maximum value 30,602,532 CZK. Award based on lowest price.
Risks
Selection criteria not detailed in the notice; bidders may face unexpected requirements from procurement documents.
Price-only award could lead to aggressive pricing and low margins.
Submission deadline in 7 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Framework agreement for supplies
Administrative
- Electronic submission required via Open portal
- Submission language: Czech (CES)
Award Criteria
Lot 1
Buyer
Name
Moravskoslezská nemocnice Frýdek-Místek, příspěvková organizace
Location
Frýdek-Místek, CZE
Website
Buyer profile
Identifier
00534188
Lots (1)
LOT-0001
Dodávky léčivých přípravků s účinnou Vedolizumab
Continuous delivery of Vedolizumab medicinal product as needed based on actual requirements and individual orders for Moravskoslezská nemocnice Frýdek-Místek.
CZK 30.6M
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Value note
Framework maximum value
Show original TED data
Original TED description
Zadavatel požaduje průběžné dodávky léčivého přípravku s účinnou látkou Vedolizumab dle aktuální potřeby zadavatele a jeho jednotlivých objednávek pro Moravskoslezskou nemocnici Frýdek-Místek, p.o.
Procurement Details
- Publication date
- 27 May 2026
- Notice type
- Contract notice — standard
- Languages
- Czech
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 366473-2026
- Source notice ID
- 48dfcf00-2f1d-45f1-b776-3366d016e6d5
Documents (1)
Similar tenders
Poland – Antineoplastic agents – Dostawa produktów leczniczych i wyrobów medycznych do Wojskowego Instytutu Medycznego – PIB
Poland – Immunoglobulins – Dostawy produktów leczniczych, wyrobów medycznych oraz substancji do receptury
Poland – Immunosuppressive agents – Dostawa środków immunosupresyjnych, produktów leczniczych dla układu nerwowego, produktów leczniczych dla organów zmysłów, środków leczniczych dla układu oddechowego, produktów leczniczych dla przewodu pokarmowego i metabolizmu, produktów leczniczych stosowanych przy cukrzycy, insuliny, płynów dożylnych, ogólnoustrojowych preparatów hormonalnych, z wyłączeniem hormonów płciowych oraz różnych...
Czechia – Immunosuppressive agents – LP s obsahem certolizumab pegolu 2026
Czechia – Immunosuppressive agents – LP s obsahem risankizumabu 2026
Czechia – Immunosuppressive agents – Ixekizumab
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
30 / 100
Risk factors
Selection criteria not detailed in the notice; bidders may face unexpected requirements from procurement documents.
Price-only award could lead to aggressive pricing and low margins.
Submission deadline in 7 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications